Evaluation of gastrin-releasing peptide receptor, prostate-specific membrane antigen, and neurotensin receptor 1 as potential biomarkers for accurate prostate cancer stratified diagnosis.

Ling XiaoZhihui FangYongxiang TangYanyan SunZehua ZhuJian LiMing ZhouNengan YangKai ZhengShuo Hu

Published in: EJNMMI research (2024)

This study presents three novel biomarkers (PSMA, GRPR, and NTR1) as imaging agents for PET/CT, and may offer a promising approach for non-invasive precise detection and Gleason grade prediction of PCa patients.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
end stage renal disease
high resolution
ejection fraction
newly diagnosed
positron emission tomography
prognostic factors
peritoneal dialysis
computed tomography
patient reported outcomes
benign prostatic hyperplasia